Starting on:
Jan 20, 2024
Ending on:
Jan 20, 2024
Moderator(s):
Max Credits:
3 Points
Provider:
Heart and Life Conferences
Claim Points
Jan 20, 2024
Ending on:
Jan 20, 2024
Moderator(s):
Dr.
Erick Njenga
Physician and Endocrinologist
Dr. Erick Njenga
Physician and Endocrinologist
Dr. Erick Njenga
physician and endocrinologist
Venue: Physician and Endocrinologist
Dr. Erick Njenga
Physician and Endocrinologist
Dr. Erick Njenga
physician and endocrinologist
Max Credits:
3 Points
Provider:
Heart and Life Conferences
Claim Points
HDL for CVD Prevention in high risk Hypertension,Diabetes and Dyslipidemia Patients
Starting on:
Jan 20, 2024
Jan 20, 2024
Ending on:
Jan 20, 2024
Jan 20, 2024
Venue:
Description
KAP Webinar Series: HDL for CVD prevention in high-risk hypertension, diabetes and dyslipidemia patients
Objectives
Hope 3 trial and its long-term follow-up
Presenters
-
Prof.
Naveed Sattar
professor of Metabolic Medicine at the Institute of Cardiovascular & Medical Sciences at the University of Glasgow
University of Glasgow